MRNS
Marinus Pharmaceuticals Inc
Price:  
1.37 
USD
Volume:  
1,125,853.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS WACC - Weighted Average Cost of Capital

The WACC of Marinus Pharmaceuticals Inc (MRNS) is 5.9%.

The Cost of Equity of Marinus Pharmaceuticals Inc (MRNS) is 6.60%.
The Cost of Debt of Marinus Pharmaceuticals Inc (MRNS) is 7.00%.

Range Selected
Cost of equity 5.40% - 7.80% 6.60%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.3% - 6.5% 5.9%
WACC

MRNS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.34 0.53
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 7.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 7.00% 7.00%
After-tax WACC 5.3% 6.5%
Selected WACC 5.9%